{"id":3246,"date":"2011-02-18T15:17:42","date_gmt":"2011-02-18T20:17:42","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=3246"},"modified":"2011-02-18T15:54:23","modified_gmt":"2011-02-18T20:54:23","slug":"finance-friday-18-february-2011","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=3246","title":{"rendered":"Finance Friday: 18 February 2011"},"content":{"rendered":"<figure id=\"attachment_142\" aria-describedby=\"caption-attachment-142\" style=\"width: 200px\" class=\"wp-caption alignright\"><a href=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/07\/CircleBenjamins_Photos8_200.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-142\" title=\"CircleBenjamins_Photos8_200\" src=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/07\/CircleBenjamins_Photos8_200.jpg\" alt=\"$100 bills in a circle (Photos8.com)\" width=\"200\" height=\"199\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/07\/CircleBenjamins_Photos8_200.jpg 200w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/07\/CircleBenjamins_Photos8_200-150x149.jpg 150w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/a><figcaption id=\"caption-attachment-142\" class=\"wp-caption-text\">(Photos8.com)<\/figcaption><\/figure>\n<p>Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by <a href=\"http:\/\/www.xconomy.com\/\">Xconomy<\/a> and elsewhere.<\/p>\n<p><strong>Biomedical\/Life Sciences<\/strong><\/p>\n<p>Rosetta Genomics Ltd. in Philadelphia, Pennsylvania. MicroRNA-based molecular diagnostics. $6.0 million, equity.<\/p>\n<p>Versartis in Mountain View, California. Protein drugs for endocrine disorders. $21 million in Series B equity financing.<\/p>\n<p>Ivivi Health Sciences in San Francisco, California. Devices for reducing post-operative pain and swelling. $4 million in new capital and conversion of a $5.5 million bridge loan into an equity stake.<\/p>\n<p>CalciMedica in San Diego, California. Biotechnology, drugs for psoriasis. $6 million in venture financing.<\/p>\n<p>Conatus Pharmaceuticals in San Diego, California. Drugs for liver disease and cancers. $20 million, equity.<\/p>\n<p>Marina Biotech in Bothell, Washington. $5.1 million in a stock offering.<\/p>\n<p><strong>Energy and Environment<\/strong><\/p>\n<p>Ze-Gen, in Boston, Massachusetts. Technology for converting solid waste into gas for power plants. $8 million, equity.<\/p>\n<p>Calisolar in Sunnyvale, California. Technology for purifying silicon in solar cells. $8 million in debt, options, and securities.<\/p>\n<p>Brightsource Energy in Oakland, California. Solar thermal plant in the Mojave Desert. $89.55 million in new equity financing.<\/p>\n<p><strong>Engineering and Electronics<\/strong><\/p>\n<p>EcoATM in San Diego, California. Automated kiosks for recycling cell phones and other devices. $14.4 million in preferred equity and venture debt financing.<\/p>\n<p>Read more, <a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=3135\">Finance Friday: 11 February 2011<\/a><\/p>\n<p style=\"text-align: center;\">*\u00a0\u00a0\u00a0\u00a0 *\u00a0\u00a0\u00a0\u00a0 *<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and elsewhere. Biomedical\/Life Sciences Rosetta Genomics Ltd. in Philadelphia, Pennsylvania. MicroRNA-based molecular diagnostics. $6.0 million, equity. Versartis in Mountain View, California. Protein drugs for endocrine disorders. $21 million in Series B equity financing. Ivivi Health Sciences in San [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[21,72,37,68,74,23,24,64,77,27,19],"class_list":["post-3246","post","type-post","status-publish","format-standard","hentry","category-finance","tag-biotech","tag-cleantech","tag-debt","tag-energy","tag-entrepreneurs","tag-equity","tag-investment","tag-life-sciences","tag-medical-device","tag-pharmaceuticals","tag-venture-capital"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/3246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3246"}],"version-history":[{"count":3,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/3246\/revisions"}],"predecessor-version":[{"id":3249,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/3246\/revisions\/3249"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}